⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4854368 | 0.89 | — | — | |
| SCHEMBL4855766 | 0.79 | — | — | |
| SCHEMBL4847839 | 0.76 | — | — | |
| SCHEMBL4854034 | 0.76 | ALOX5 (0.42) | — | |
| SCHEMBL6691869 | 0.73 | LMNA (0.36) | — | |
| SCHEMBL4846875 | 0.72 | — | — | |
| SCHEMBL4849553 | 0.70 | TYR (0.42) | — | |
| SCHEMBL6700599 | 0.69 | TYR (0.33) | — | |
| SCHEMBL6693107 | 0.69 | — | — | |
| SCHEMBL14868847 | 0.68 | ALOX5 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040063780-A1 | Pharmaceutical preparations for treatment of type II diabetes and methods for treatment of type II diabetes | CHUGAI SEIYAKU KABUSHIKI KAISHA | 2004-04-01 | — | — | US | disclosed |